HLscience Co., Ltd. (KOSDAQ:239610)

HLscience Statistics

Total Valuation

HLscience has a market cap or net worth of KRW 40.13 billion. The enterprise value is 12.14 billion.

Market Cap	40.13B
Enterprise Value	12.14B

Important Dates

The next estimated earnings date is Wednesday, March 18, 2026.

Earnings Date	Mar 18, 2026
Ex-Dividend Date	n/a

Share Statistics

HLscience has 5.09 million shares outstanding.

Current Share Class	5.09M
Shares Outstanding	5.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	66.98%
Owned by Institutions (%)	n/a
Float	1.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.22
PB Ratio	0.46
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.07
EV / Sales	0.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.16

Financial Position

The company has a current ratio of 22.97

Current Ratio	22.97
Quick Ratio	19.79
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,869.12

Financial Efficiency

Return on equity (ROE) is -12.20% and return on invested capital (ROIC) is -21.10%.

Return on Equity (ROE)	-12.20%
Return on Assets (ROA)	-8.19%
Return on Invested Capital (ROIC)	-21.10%
Return on Capital Employed (ROCE)	-14.20%
Weighted Average Cost of Capital (WACC)	9.15%
Revenue Per Employee	212.93M
Profits Per Employee	-133.17M
Employee Count	85
Asset Turnover	0.19
Inventory Turnover	2.48

Taxes

In the past 12 months, HLscience has paid 409.57 million in taxes.

Income Tax	409.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.36% in the last 52 weeks. The beta is 0.89, so HLscience's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-35.36%
50-Day Moving Average	8,247.20
200-Day Moving Average	10,657.20
Relative Strength Index (RSI)	43.54
Average Volume (20 Days)	3,982

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLscience had revenue of KRW 18.10 billion and -11.32 billion in losses. Loss per share was -2,223.00.

Revenue	18.10B
Gross Profit	7.49B
Operating Income	-12.50B
Pretax Income	-10.94B
Net Income	-11.32B
EBITDA	-9.94B
EBIT	-12.50B
Loss Per Share	-2,223.00

Balance Sheet

The company has 28.16 billion in cash and n/a in debt, with a net cash position of 28.16 billion or 5,529.69 per share.

Cash & Cash Equivalents	28.16B
Total Debt	n/a
Net Cash	28.16B
Net Cash Per Share	5,529.69
Equity (Book Value)	87.36B
Book Value Per Share	17,120.00
Working Capital	33.07B

Cash Flow

In the last 12 months, operating cash flow was -5.05 billion and capital expenditures -583.57 million, giving a free cash flow of -5.63 billion.

Operating Cash Flow	-5.05B
Capital Expenditures	-583.57M
Free Cash Flow	-5.63B
FCF Per Share	-1,106.23

Margins

Gross margin is 41.36%, with operating and profit margins of -69.06% and -62.54%.

Gross Margin	41.36%
Operating Margin	-69.06%
Pretax Margin	-60.42%
Profit Margin	-62.54%
EBITDA Margin	-54.93%
EBIT Margin	-69.06%
FCF Margin	n/a

Dividends & Yields

HLscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-28.21%
FCF Yield	-14.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.05

Scores

HLscience has an Altman Z-Score of 18.87 and a Piotroski F-Score of 2.

Altman Z-Score	18.87
Piotroski F-Score	2